The role of tissue factor in systemic inflammatory response syndrome

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 6, 2011, Pages 451-456

  Egorina, Elena M ^a,b   Sovershaev, Mikhail A ^a,b   Hansen, John Bjarne ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

blood coagulation; inflammation; monocytes; systemic inflammatory response syndrome; tissue factor

Indexed keywords

LIPOPOLYSACCHARIDE; THROMBOPLASTIN;

DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTOXEMIA; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANTI-BACTERIAL AGENTS; BLOOD COAGULATION; DISSEMINATED INTRAVASCULAR COAGULATION; GRAM-NEGATIVE BACTERIA; HUMANS; LIPOPOLYSACCHARIDES; MONOCYTES; SEPSIS; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOPLASTIN;

EID: 80052092421     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328346ef3f     Document Type: Review

References (68)

1. Aird WC. Coagulation. Crit Care Med 2005; 33:S485-S487.
2. Gando S, Kameue T, Nanzaki S, Hayakawa T, Nakanishi Y. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome. Crit Care Med 1997; 25:1820-1826. (Pubitemid 27483961)
3. Stief TW, Ijagha O, Weiste B, Herzum I, Renz H, Max M. Analysis of hemostasis alterations in sepsis. Blood Coagul Fibrinolysis 2007; 18:179-186. (Pubitemid 46232840)
4. Gando S. Disseminated intravascular coagulation in trauma patients. Semin Thromb Hemost 2001; 27:585-592. (Pubitemid 33152571)
5. McEachron TA, Pawlinski R, Richards KL, Church FC, Mackman N. Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis. Blood 2010; 116:5037-5044.
6. Broze GJ Jr. Binding of human factor VII and VIIa to monocytes. J Clin Invest 1982; 70:526-535. (Pubitemid 12054576)
7. Mann KG. Thrombin: can't live without it; probably die from it. Chest 2003; 124:1S-3S. (Pubitemid 37128429)
8. Mackman N. Role of tissue factor in hemostasis and thrombosis. Blood Cells Mol Dis 2006; 36:104-107.
9. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24:1015-1022.
10. Rak J, Yu JL, Luyendyk J, Mackman N. Oncogenes, Trousseau syndrome, and cancer-related changes in the coagulome of mice and humans. Cancer Res 2006; 66:10643-10646. (Pubitemid 44876956)
11. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134:1087-1097. (Pubitemid 19142892)
12. Osterud B. Tissue factor expression in blood cells. Thromb Res 2010; 125 (Suppl 1):S31-34.
13. Egorina EM, Sovershaev MA, Bjorkoy G, Gruber FX, Olsen JO, Parhami-Seren B, et al. Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler Thromb Vasc Biol 2005; 25:1493-1498. (Pubitemid 40923374)
14. Egorina EM, Sovershaev MA, Olsen JO, Osterud B. Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer. Blood 2008; 111:1208-1216. (Pubitemid 351213402)
15. Gillis P, Malter JS. The adenosine-uridine binding factor recognizes the AU-rich elements of cytokine, lymphokine, and oncogene mRNAs. J Biol Chem 1991; 266:3172-3177. (Pubitemid 21909190)
16. Bona R, Lee E, Rickles F. Tissue factor apoprotein: intracellular transport and expression in shed membrane vesicles. Thromb Res 1987; 48:487-500.
17. Egorina EM, Sovershaev MA, Osterud B. Regulation of tissue factor procoagulant activity by posttranslational modifications. Thromb Res 2008; 122:831-837.
18. Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81:1-41. (Pubitemid 26027721)
19. Chen VM, Hogg PJ. Allosteric disulfide bonds in thrombosis and thrombolysis. J Thromb Haemost 2006; 4:2533-2541. (Pubitemid 44741542)
20. Bach RR, Monroe D. What is wrong with the allosteric disulfide bond hypothesis? Arterioscler Thromb Vasc Biol 2009; 29:1997-1998.
21. Kothari H, Nayak RC, Rao LV, Pendurthi UR. Cystine 186-cystine 209 disulfide bond is not essential for the procoagulant activity of tissue factor or for its de-encryption. Blood 2010; 115:4273-4283.
22. Ahamed J, Versteeg HH, Kerver M, Chen VM, Mueller BM, Hogg PJ, et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci USA 2006; 103:13932-13937. (Pubitemid 44452960)
23. Chen VM, Ahamed J, Versteeg HH, Berndt MC, Ruf W, Hogg PJ. Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry 2006; 45:12020-12028. (Pubitemid 44497827)
24. Bach RR. Tissue factor encryption. Arterioscler Thromb Vasc Biol 2006; 26:456-461.
25. Dorfleutner A, Ruf W. Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation. Blood 2003; 102:3998-4005. (Pubitemid 37486981)
26. Breimo ES, Osterud B. Generation of tissue factor-rich microparticles in an ex vivo whole blood model. Blood Coagul Fibrinolysis 2005; 16:399-405. (Pubitemid 41215733)
27. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874.
28. Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28:108-121. (Pubitemid 34293822)
29. Modlin RL, Brightbill HD, Godowski PJ. The toll of innate immunity on microbial pathogens. N Engl J Med 1999; 340:1834-1835. (Pubitemid 29266411)
30. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365:63-78.
31. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-793. (Pubitemid 26372655)
32. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256. (Pubitemid 36444440)
33. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554. (Pubitemid 36437931)
34. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991; 88:1747-1754.
35. Osterud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost 1983; 49:5-7. (Pubitemid 13144355)
36. Franco RF, de Jonge E,Dekkers PE, Timmerman JJ, Spek CA, van Deventer SJ, et al. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood 2000; 96:554-559. (Pubitemid 30463375)
37. Aras O, Shet A, Bach RR, Hysjulien JL, Slungaard A, Hebbel RP, et al. Induction of microparticle-and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004; 103:4545-4553. (Pubitemid 38745982)
38. de Kruif MD, Lemaire LC, Giebelen IA, van Zoelen MA, Pater JM, van den Pangaart PS, etal. Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia. J Immunol 2007; 178:1845-1851. (Pubitemid 46154657)
39. Koyama T, Nishida K, Ohdama S, Sawada M, Murakami N, Hirosawa S, et al. Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol 1994; 87:343-347. (Pubitemid 24204737)
40. Pawlinski R, Pedersen B, Schabbauer G, Tencati M, Holscher T, Boisvert W, et al. Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 2004; 103:1342-1347. (Pubitemid 38168646)
41. Stief TW, Ulbricht K, Max M. Circulating thrombin activity in sepsis. In: Stief TW, editor. Hemostasis laboratory yearbook. Hauppauge, NY: Nova Science Publishers; 2010. pp. 293-306.
42. Salgado A, Boveda JL, Monasterio J, Segura RM, Mourelle M, Gomez-Jimenez J, et al. Inflammatory mediators and their influence on haemostasis. Haemostasis 1994; 24:132-138. (Pubitemid 24234491)
43. Hollenstein UM, Pernerstorfer T, Homoncik M, Hansen JB, Finzen H, Handler S, et al. Effect of factor X inhibition on coagulation activation and cytokine induction in human systemic inflammation. J Infect Dis 2002; 186:1270-1276. (Pubitemid 35193005)
44. Osterud B, Bjorklid E. The tissue factor pathway in disseminated intravascular coagulation. Semin Thromb Hemost 2001; 27: 605-617. (Pubitemid 33152573)
45. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341:586-592. (Pubitemid 29384168)
46. Asakura H, Kamikubo Y, Goto A, Shiratori Y, Yamazaki M, Jokaji H, et al. Role of tissue factor in disseminated intravascular coagulation. Thromb Res 1995; 80:217-224.
47. Koyama T, Ohdama S, Aoki N. Plasma tissue factor reflects endothelial cell injury rather than upregulation of tissue factor expression. Thromb Haemost 1997; 78:972.
48. Russell JA. Management of sepsis. N Engl J Med 2006; 355:1699-1713. (Pubitemid 44583960)
49. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085-2088. (Pubitemid 29001265)
50. Herrera-Velit P, Knutson KL, Reiner NE. Phosphatidylinositol 3-kinase-dependent activation of protein kinase C-zeta in bacterial lipopolysaccharide-treated human monocytes. J Biol Chem 1997; 272:16445-16452. (Pubitemid 27276471)
51. Sweet MJ, Hume DA. Endotoxin signal transduction in macrophages. J Leukoc Biol 1996; 60:8-26. (Pubitemid 26248877)
52. Lee FS, Hagler J, Chen ZJ, Maniatis T. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell 1997; 88:213-222. (Pubitemid 28015870)
53. Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A, et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 1999; 13:1015-1024. (Pubitemid 29200984)
54. Akashi S, Shimazu R, Ogata H, Nagai Y, Takeda K, Kimoto M, et al. Cutting edge: cell surface expression and lipopolysaccharide signaling via the tolllike receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 2000; 164:3471-3475. (Pubitemid 30169795)
55. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993; 268:14553-14556. (Pubitemid 23206581)
56. Hall AJ, Vos HL, Bertina RM. Lipopolysaccharide induction of tissue factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor kappaB nuclear translocation. J Biol Chem 1999; 274:376-383. (Pubitemid 29035071)
57. Mackman N. Regulation of the tissue factor gene. Thromb Haemost 1997; 78:747-754.
58. Erlich J, Fearns C, Mathison J, Ulevitch RJ, Mackman N. Lipopolysaccharide induction of tissue factor expression in rabbits. Infect Immun 1999; 67:2540-2546. (Pubitemid 29200516)
59. Hoffman M, Cooper ST. Thrombin enhances monocyte secretion of tumor necrosis factor and interleukin-1 beta by two distinct mechanisms. Blood Cells Mol Dis 1995; 21:156-167.
60. Pawlinski R, Mackman N. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit Care Med 2004; 32:S293-S297.
61. Mackman N, Taubman M. Tissue factor: past, present, and future. Arterioscler Thromb Vasc Biol 2009; 29:1986-1988.
62. Niessen F, Furlan-Freguia C, Fernandez JA, Mosnier LO, Castellino FJ, Weiler H, et al. Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality. Blood 2009; 113:2859-2866.
63. Camerer E, Trejo J. Cryptic messages: is noncoagulant tissue factor reserved for cell signaling? Proc Natl Acad Sci USA 2006; 103:14259-14260. (Pubitemid 44484736)
64. Holy EW, Tanner FC. Tissue factor in cardiovascular disease pathophysiology and pharmacological intervention. Adv Pharmacol 2010; 59:259-292.
65. Wunderink RG, Laterre PF, Francois B, Perrotin D, Artigas A, Vidal LO, et al. Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2011. doi: 201007-1167OCv1
66. Hedner U. History of rFVIIa therapy. Thromb Res 2010; 125 (Suppl 1): S4-S6.
67. Van Den Boogaard FE, BrandsX, Schultz MJ, Levi M,Roelofs JJ, Van 't Veer C, et al. Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia. J Thromb Haemost 2011; 9:122-132.
68. Mackman N. The role of tissue factor and factor VIIa in hemostasis. Anesth Analg 2009; 108:1447-1452.